Clinical Trial Update: EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial sponsored by ASTEROGENE Biomedical Co. Ltd. is recruiting to evaluate autologous nucleus pulposus cells (aNPC) for intervertebral dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intervertebral Disc Degeneration

Drugs mentioned

• Autologous Nucleus Pulposus Cells (aNPC) Therapy (autologous nucleus pulposus cell therapy)

Snippet

Sponsor: ASTEROGENE Biomedical Co. Ltd. | Conditions: Intervertebral Disc Degeneration | Phase 1, Phase 2 | Status: RECRUITING